CN Bio Innovations announces Hepatitis B research collaboration with leading pharmaceutical company

Welwyn Garden City, UK, 21st April 2015: CN Bio Innovations, an expert in developing human organ-on-a-chip platforms to test and develop therapeutics for liver diseases and infection, is pleased to announce the commencement of a research collaboration with a third (undisclosed) pharmaceutical company. The research, which will take advantage of CN Bio’s full viral lifecycle model of Hepatitis B, Quantum-B®, will be performed by CN Bio in the company’s newly opened Containment Level 3 laboratory in Welwyn Garden City, UK.

filed under: Business